{"id":"https://openalex.org/W2188347645","doi":null,"title":"COCERIG ISSUES WITH BIOSIMILARS: AOVERVIEW","display_name":"COCERIG ISSUES WITH BIOSIMILARS: AOVERVIEW","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188347645","mag":"2188347645"},"language":"en","primary_location":{"id":"mag:2188347645","doi":null,"is_oa":false,"landing_page_url":"https://pharmacologyonline.silae.it/files/newsletter/2011/vol1/083.reddy.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2188347645"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045825592","display_name":"Usha Rani Swarna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Usha Rani Swarna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006225791","display_name":"Sahith Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sahith Reddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Sanjay Bharati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanjay Bharati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.996999979019165},{"id":"https://openalex.org/keywords/biopharmaceuticals","display_name":"biopharmaceuticals","score":0.9810000061988831},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.6200000047683716},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.671999990940094},{"id":"https://openalex.org/keywords/pharmacokinetic-similarity","display_name":"pharmacokinetic similarity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/protein-characterization","display_name":"protein characterization","score":0.5839999914169312},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.6430000066757202},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9906891584396362},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.9207287430763245},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.6886262893676758},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5664797425270081},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.47055792808532715},{"id":"https://openalex.org/C2779606619","wikidata":"https://www.wikidata.org/wiki/Q17092524","display_name":"Interchangeability","level":2,"score":0.42842862010002136},{"id":"https://openalex.org/C2908701176","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biological drugs","level":3,"score":0.4271474778652191},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4060061275959015},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.3886071741580963},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3388259708881378},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3214745819568634},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2353348433971405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2030988335609436},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18127170205116272},{"id":"https://openalex.org/C34974158","wikidata":"https://www.wikidata.org/wiki/Q131257","display_name":"Intellectual property","level":2,"score":0.12202882766723633},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188347645","doi":null,"is_oa":false,"landing_page_url":"https://pharmacologyonline.silae.it/files/newsletter/2011/vol1/083.reddy.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1969438932","https://openalex.org/W1976513080","https://openalex.org/W1989294892","https://openalex.org/W2016091975","https://openalex.org/W2018263538","https://openalex.org/W2039211544","https://openalex.org/W2057101259","https://openalex.org/W2078716707","https://openalex.org/W2084735047","https://openalex.org/W2100518445","https://openalex.org/W2117738445","https://openalex.org/W2141989396","https://openalex.org/W2151188170","https://openalex.org/W2157584018","https://openalex.org/W2158270313","https://openalex.org/W2162244174","https://openalex.org/W2341245113"],"related_works":["https://openalex.org/W2117738445","https://openalex.org/W2151188170","https://openalex.org/W2086689296","https://openalex.org/W2106629384","https://openalex.org/W1629918075","https://openalex.org/W102407795","https://openalex.org/W80108746","https://openalex.org/W2185685602","https://openalex.org/W2401519681"],"abstract_inverted_index":{"Summary":[0],"Biopharmaceuticals":[1],"are":[2,129],"biological":[3,84],"medicinal":[4],"products":[5,29,154],"that":[6,107,119,128],"have":[7],"been":[8],"developed":[9],"through":[10],"biotechnological":[11],"practices,":[12],"including":[13],"recombinant":[14],"human":[15],"technology,":[16],"gene":[17],"technology":[18],"or":[19,146],"antibody":[20],"methods.":[21],"The":[22],"imminent":[23],"patent":[24],"expiration":[25],"of":[26,37,61,75,88,95,125,142,148,162],"many":[27,52],"biopharmaceutical":[28,153],"will":[30,66,155],"produce":[31],"the":[32,57,62,68,73,76,86,89,93,143],"possibility":[33],"for":[34,71,168],"generic":[35,45],"versions":[36],"these":[38],"therapeutic":[39],"agents":[40],"(i.e.biosimilars).":[41],"Biosimilars":[42],"differ":[43],"from":[44],"low":[46],"molecular":[47],"weight":[48],"chemical":[49],"drugs":[50],"in":[51],"important":[53],"ways.":[54],"These":[55],"include":[56],"size":[58],"and":[59,82,92,101,122],"complexity":[60,87],"active":[63],"substance,":[64],"which":[65,165],"affect":[67],"scientific":[69],"requirement":[70],"testing;":[72],"nature":[74],"starting":[77],"materials":[78],"(cell":[79],"banks,":[80],"tissues,":[81],"other":[83],"products);":[85],"manufacturing":[90],"processes;":[91],"limitations":[94],"state-ofthe-art":[96],"methods":[97],"to":[98,102,131,138,145],"characterize":[99],"proteins":[100],"detect":[103],"all":[104],"product":[105],"variations":[106],"can":[108],"influence":[109],"clinical":[110],"efficacy,":[111],"sideeffects":[112],"like":[113],"immunogenicity.":[114],"Therefore,":[115],"it":[116],"was":[117],"acknowledged":[118],"established":[120],"legal":[121],"regulatory":[123],"principles":[124],"\u2018essential":[126],"similarity\u2019":[127],"applied":[130,137],"standard":[132],"generics":[133],"cannot":[134],"be":[135],"readily":[136],"biosimilars.":[139],"Thus,":[140],"verification":[141],"similarity":[144],"substitutability":[147],"biosimilars":[149],"with":[150],"reference":[151],"innovator":[152],"require":[156],"much":[157],"more":[158],"than":[159],"a":[160],"demonstration":[161],"pharmacokinetic":[163],"similarity,":[164],"is":[166],"sufficient":[167]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2188347645","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
